ProAxsis specialises in the development and commercialisation of in vitro diagnostic laboratory assays and point–of–care tests designed to measure active protease biomarkers of disease.
Causeway Sensors are revolutionising the discovery and development of biotherapeutics using label–free plasmonic nanostructures